KPTI
Karyopharm Therapeutics Inc
0.645$
-0.8%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.2% | -0.3% | -68.9% | +2,636.3% | -2.1% | -96.8% | -153.8% | – | -84.3% | -36.8% | -125.0% | – | |
| – | +2.0% | -4.1% | +8.9% | -22.7% | -7.6% | -7.9% | +6.3% | -25.9% | +39.2% | -23.0% | -35.8% | – | |
| – | +777.8% | -175.9% | – | – | +34.6% | -115.1% | – | +41.8% | -61.4% | -30.0% | -67.0% | – | |
| – | – | – | -100.0% | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | -18.3% | +133.6% | -85.4% | +98.0% | +3.3% | +19.6% | -73.7% | +4.1% | -36.0% | -413.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -99.3% | – | – | -100.0% | – | -100.0% | – | -100.0% | – | +67.7% | -101.8% | – | |
| – | – | -353.2% | – | -122.2% | – | – | – | – | – | +32.5% | -218.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.